Despite the established mortality benefit, published guidelines differ in their recommendations for screening mammography due to variations in the perceptions of the relative risks and benefits [5,38]. The degree of breast cancer mortality reduction from screening mammography varies with different screening...
The appropriateness of the above-referenced tools is presented here as they apply to a variety of findings often encountered on screening mammography; an algorithmic approach to workup of these potential scenarios is also included. The recommendations put forth represent a compilation of evidence-based...
Although recall and biopsy recommendations are higher with more frequent screening, so are life-years gained and breast cancer deaths averted. Women who wish to maximize bene?t will choose annual screening starting at age 40 years and will not stop screening prematurely. Key Words: Breast cancer,...
2016+ACR适宜性标准：乳腺癌筛查 ORIGINAL ARTICLE ACR Appropriateness Criteria Breast Cancer Screening Martha B.Mainiero,MD a,Ana Lourenco,MD a,Mary C.Mahoney,MD b,Mary S.Newell,MD c, Lisa Bailey,MD d,e,Lora D.Barke,DO f,Carl D’Orsi,MD c,Jennifer A.Harvey,MD g,Mary K.Hayes,MD h,...
modalities (except MRI does not allow for 4A, B or C) Assessment Categories included management recommendations Management recommendations separated from Assessment Categories (to allow for the occasions where discordance between assessment and management is necessary) ...
Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast ImagingBreast cancerbreast cancer screeningearly detectionmammographymammography screeningBreast cancer remains the most common nonskin cancer, the second leading cause of cancer deaths,...
2016+ACR适宜性标准：乳腺癌筛查 2016+ACR适宜性标准：乳腺癌筛查 ORIGINAL ARTICLE ACR Appropriateness Criteria Breast Cancer Screening Martha B.Mainiero,MD a,Ana Lourenco,MD a,Mary C.Mahoney,MD b,Mary S.Newell,MD c, Lisa Bailey,MD d,e,Lora D.Barke,DO f,Carl D’Orsi,MD c,Jennifer A....
For BRCA gene mutation carriers, MRI was initially recommended as a supplemental screening modality starting at age 25, to be obtained in addition to annual mammography at and beyond age 30. That recommendation remains solid. Since our previous recommendations, there are additional outcome data confir...
Does training in the Breast Imaging Reporting and Data System (BI-RADS) improve biopsy recommendations or feature analysis agreement with experienced breast imagers at mammography? Radiology (2002) R.D.Rosenberget al. Performance benchmarks for screening mammography ...
For CAD-RADS 4, recommendations may vary depending on whether the left main or severe obstructive three-vessel disease (>70%) is affected or not. If a left main coronary artery stenosis greater than 50% is suspected or if the examination demonstrates three-vessel obstructive disease, then ...